Location · Lubbock, TX
Clinical trials in Lubbock, TX
30 recruiting studies have a site in Lubbock, and 11 of them accept healthy volunteers.
30 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Xencor, Inc.
- Location
- Lubbock, TX + 27 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1/Phase 2
Annatto-derived GG for Statin-associated Myopathy
Texas Tech University Health Sciences Center
- Location
- Lubbock, TX
- Eligibility basics
- Ages 40+
- RecruitingHealthy volunteersEarly Phase 1
Zynrelef vs Exparel: The Battle of Postoperative Pain Control After Robotic Sleeve Gastrectomy
Texas Tech University Health Sciences Center
- Location
- Lubbock, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
ACT for Individuals With MNCD and Their Care Partners
Texas Tech University
- Location
- Lubbock, TX
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
Curcumin and Retinal Study
Texas Tech University Health Sciences Center
- Location
- Lubbock, TX
- Eligibility basics
- Ages 40–89
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Merck Sharp & Dohme LLC
- Location
- Lubbock, TX + 70 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sanofi
- Location
- Lubbock, TX + 33 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 2
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Palisade Bio
- Location
- Lubbock, TX + 27 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 4
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Takeda
- Location
- Lubbock, TX + 77 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
AbbVie
- Location
- Lubbock, TX + 60 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sanofi
- Location
- Lubbock, TX + 36 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Ambros Therapeutics, Inc.
- Location
- Lubbock, TX + 29 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Takeda
- Location
- Lubbock, TX + 45 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Eli Lilly and Company
- Location
- Lubbock, TX + 36 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.
Neuraptive Therapeutics Inc.
- Location
- Lubbock, TX + 22 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Merck Sharp & Dohme LLC
- Location
- Lubbock, TX + 11 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
- Location
- Lubbock, TX + 55 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Hoffmann-La Roche
- Location
- Lubbock, TX + 58 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 2
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
AbbVie
- Location
- Lubbock, TX + 53 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
- Location
- Lubbock, TX + 35 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Takeda
- Location
- Lubbock, TX + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Aurinia Pharmaceuticals Inc.
- Location
- Lubbock, TX + 26 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Immunovant Sciences GmbH
- Location
- Lubbock, TX + 47 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Mirador Therapeutics, Inc.
- Location
- Lubbock, TX + 42 other US sites
- Eligibility basics
- Ages 18–80